Bartley J. Madden is an independent researcher whose current focus is on market-based solutions to public policy issues. He has written extensively about a proposed dual-track system to circumvent the FDA’s monopoly on access to not-yet-approved drugs and to enable patients and doctors to make informed decisions on the use of such drugs. His Shareholder Value Review proposal to improve both corporate governance and the long-term performance of companies is explained in this book. His professional career began with engineering work followed by an MBA at the University of California at Berkeley. In 1969, he co-founded Callard, Madden & Associates in order to develop a more useful valuation framework for both institutional money managers and corporate managements. His research was instrumental in developing the CFROI life-cycle valuation model widely used by many large money management firms today. After managing portfolios for Harbor Capital Advisors, he became a partner at HOLT Value Associates in the early 1990s, a firm created to commercialize the CFROI framework worldwide. His book,
CFROI Valuation: A Total System Approach to Valuing the Firm, was published by Butterworth-Heinemann in 1999. Credit Suisse acquired HOLT in 2002. Since retiring as a managing director at Credit Suisse, he has published a variety of journal articles and monographs that can be accessed on his web site,
www.LearningWhatWorks.com.